Navigation Links
Bacterial communication encourages chronic, resistant ear infections

Ear infections caused by more than one species of bacteria could be more persistent and antibiotic-resistant because one pathogen may be communicating with the other, encouraging it to bolster its defenses. Interrupting or removing that communication could be key to curing these infections. Researchers from Wake Forest University Baptist Medical Center publish their findings today in mBio, the online open-access journal of the American Society for Microbiology.

"In this study we show that communication between bacterial species promotes bacterial persistence and resistance to antibiotics, which are important considerations in the diagnosis, preventions and treatment of otitis media (OM)," says W. Edward Swords, an associate professor of microbiology and immunology and senior author of the study. Chelsie Armbruster, a Ph.D. student working in Swords' lab, co-authored the study.

OM is one of the most common childhood infections and is the leading reason for pediatric office visits and new antibiotic prescriptions to children. OM infections often persist for long periods of time and are often resistant to antibiotics. These chronic and recurrent cases of OM involve the persistence of the bacteria within a biofilm community, a state in which they are highly resistant to both natural clearance by the immune system and antibiotic treatment.

Epidemiological data indicate that the majority of chronic OM infections are polymicrobial in nature, meaning they are caused by more than one species of bacteria. Haemophilus influenzae and Moraxella catarrhalis are frequently found together in samples obtained from patients with chronic and recurrent OM.

"Interestingly, a recent study found M. catarrhalis to be more frequently associated with polymicrobial OM infections than from single-species OM infections. This suggests that the presence of other bacterial pathogens may impact the persistence of M. catarrhalis or the severity of disease caused by this species," says Swords.

In examining the dynamics between these two bacteria in culture and animal models, Swords and his colleagues discovered the H. influenzae secreted autoinducer-2 (AI-2), a chemical involved in an interbacterial method of communication known as quorum sensing, that promoted increased biofilm formation and antibiotic resistance in M. catarrhalis.

"We conclude that H. influenzae promotes M. catarrhalis persistence within polymicrobial infection biofilms via inter-species quorum signaling. AI-2 may therefore represent an ideal target for disruption of chronic polymicrobial infections," says Swords. "Moreover, these results strongly imply that successful vaccination against the unencapsulated H. influenzae strains that cause airway infections may also significantly impact chronic M. catarrhalis disease by removing a reservoir for the AI-2 signal that promotes M. catarrhalis persistence within biofilms."


Contact: Garth Hogan
American Society for Microbiology

Related medicine news :

1. FDA to Re-examine Anti-Bacterial Chemical in Soaps, Cleansers
2. Bacterial phylotype alterations in irritable bowel syndrome
3. Lexington Health Care Chooses OnShift for Nurse Scheduling and Employee Communications in all Facilities
4. Mayo Clinic Proceedings: Gabapentin opens window of communication
5. Online Housecalls, Improved Patient Care and Increased Communication Between Doctors and Healthcare Professionals Now Made Possible Through
6. NTUs Wee Kim Wee School of Communication to host International Communication Association Conference
7. Communication Program Didnt Improve Autism Symptoms
8. iPBX Hosted Communications Service from DSCI Now Includes Bria Softphone
9. Users Increase Sales and Marketing Communications 320 Percent
10. First Communications, Inc. Announces Audited Results for the Year Ended December 31, 2009
11. Esna Technologies Receives Unified Communications Magazine's 2009 Product of the Year Award
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: